ROS-responsive hydrogel patch orchestrating macrophage reprogramming and mitochondrial protection for post-MI repair.

This study investigated salvianolic acid B (DB), a compound found in the traditional Chinese medicinal herb Salvia miltiorrhiza (Danshen), for treating heart damage after a heart attack. Researchers used computer analysis to identify DB as a promising treatment and confirmed that when given orally, it improved heart function in laboratory studies. However, oral DB has poor absorption in the body, limiting its effectiveness. To solve this problem, scientists developed an innovative injectable hydrogel patch that delivers DB directly to damaged heart tissue. The patch is designed to respond to oxidative stress—the harmful chemical environment present after a heart attack—releasing the medication exactly where and when it's needed. In mouse studies, a single application of this patch significantly reduced scarring, promoted new blood vessel growth, and restored heart function. This research represents an important bridge between traditional herbal medicine and modern biotechnology. While Danshen has been used in Traditional Chinese Medicine for cardiovascular conditions for centuries, this study provides scientific validation of its active components and creates a novel delivery method that maximizes therapeutic benefits. For patients considering acupuncture and Traditional Chinese Medicine approaches for cardiovascular health, this research supports the pharmacological basis of herbal therapies traditionally used alongside acupuncture, though clinical applications in humans require further study. Patients interested in integrative approaches to cardiovascular care should consult with a qualified, licensed acupuncturist familiar with both traditional herbal medicine and modern cardiac care.

This study employed network pharmacology to identify salvianolic acid B (DB) from Salvia miltiorrhiza as a therapeutic candidate for myocardial infarction. While oral DB demonstrated efficacy in functional and histological assessments, poor bioavailability necessitated an alternative delivery approach. Researchers developed a ROS-responsive injectable hydrogel composed of whey protein isolate methacrylate and o-nitrobenzyl alcohol modified hyaluronic acid, incorporating DB-loaded liposomes for localized, on-demand release. In murine MI models, single hydrogel administration significantly attenuated fibrosis, enhanced angiogenesis, and restored cardiac function. The study validates pharmacological mechanisms underlying Danshen's traditional cardiovascular applications while demonstrating proof-of-concept for responsive biomaterial drug delivery. This research supports the integration of evidence-based herbal pharmacology with conventional post-infarction care. Clinical translation requires human trials, but findings reinforce the scientific basis for Salvia miltiorrhiza in TCM cardiovascular protocols, particularly when combined with acupuncture for comprehensive post-MI management.